A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Midodrine

Midodrine stimulates alpha-adrenergic receptors, used for nasal congestion, glaucoma, or ADHD.

First FDA approval2003-09-11
Generic availableYes · 13 mfrs
Shortage statusDiscontinued
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$153.5M in CY2024 Part D spend2.5M claims · 761K beneficiaries · 329 plans surveyed

Lowest NADAC
$0.073/unit
20 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.073
Across all dosage forms in distribution.
Highest NADAC
$0.073
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema10 entries indexed · 4 visible
What is Midodrine used for?

Midodrine stimulates alpha-adrenergic receptors, used for nasal congestion, glaucoma, or ADHD.

Is there a generic for Midodrine?

Yes. 39 ANDAs filed at FDA, 13 generic manufacturers currently shipping.

How much does my plan pay for Midodrine?

Across 329 Part D plans, Midodrine averages $0.073/unit (NADAC). Lowest available: $0.073/unit. Highest in distribution: $0.073/unit.

Is Midodrine on the FDA shortage list?

Midodrine has been discontinued by its manufacturer(s).

6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

alpha-Adrenergic Agonist6 alternatives in D1
01
Adrenalin (Epinephrine)
alpha-Adrenergic Agonist
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
02
Adrenalin(R)
alpha-Adrenergic Agonist
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
03
Auvi-Q
alpha-Adrenergic Agonist
$297.57Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
04
Brimonidine
Brand: ALPHAGAN P
$0.525Lowest NADAC
11Generic mfrs
$267.0MCY24 Part D spend
Compare →
05
Brimonidine and Timolol
Brand: Brimonidine Tartrate/Timolol Maleate
$2.30Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
06
Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide
Brand: Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide
$0.074Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.